Association of Higher-Dose Fluoroquinolone Therapy With Serious Adverse Events in Older Adults With Advanced Chronic Kidney Disease

IMPORTANCE: Population-based data are needed to inform the safe prescribing of fluoroquinolone antibiotics to patients with advanced chronic kidney disease (CKD). OBJECTIVE: To quantify the 14-day risk of a hospital visit with nervous system and/or psychiatric disorders, hypoglycemia, or a collagen-...

Descripción completa

Detalles Bibliográficos
Autores principales: Muanda, Flory Tsobo, Sood, Manish M., Weir, Matthew A., Sontrop, Jessica M., Ahmadi, Fatemeh, Yoo, Elisa, Kim, Richard B., Silverman, Michael S., Knoll, Gregory A., Garg, Amit X.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346548/
https://www.ncbi.nlm.nih.gov/pubmed/35917124
http://dx.doi.org/10.1001/jamanetworkopen.2022.24892

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346548/
https://www.ncbi.nlm.nih.gov/pubmed/35917124
http://dx.doi.org/10.1001/jamanetworkopen.2022.24892

Ejemplares similares